Unprecedented benefit seen in worldwide test of a three-drug treatment for multiple myeloma
Monday, December 8, 2014 - 16:01
in Health & Medicine
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team.